Long-term follow-up of metachronous marrow-kidney transplantation in severe type II sialidosis: What does success mean?

Nephrology Dialysis Transplantation

Volumn 20, Issue 11, 2005, Pages 2563-2565

  Schiff, Manuel ^a   Maire, Irène ^a   Bertrand, Yves ^b   Cochat, Pierre ^a   Guffon, Nathalie ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b HÔPITAL DEBROUSSE   (France)

Author keywords

Bone marrow transplantation; Inborn metabolic diseases; Lysosomal storage diseases; Nephrosialidosis; Neuraminidase deficiency; Renal transplantation; Type II sialidosis

Indexed keywords

OLIGOSACCHARIDE; SIALIDASE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANOREXIA; ARTICLE; BONE RADIOGRAPHY; CADAVER KIDNEY; CASE REPORT; CHILD; DISEASE SEVERITY; EYE DISEASE; FACE DYSMORPHIA; FAILURE TO THRIVE; FEMALE; FOLLOW UP; HEMODIALYSIS; HEPATOMEGALY; HUMAN; HUMAN CELL; HUMAN TISSUE; HURLER SYNDROME; HYDRAMNIOS; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; KYPHOSCOLIOSIS; LONG TERM CARE; MALNUTRITION; MENTAL DISEASE; MUSCLE HYPOTONIA; PERIPHERAL EDEMA; PHYSICAL DISABILITY; PRIORITY JOURNAL; PROTEINURIA; PSYCHOMOTOR RETARDATION; SIALIDOSIS; SPLENOMEGALY; VOMITING;

BONE MARROW TRANSPLANTATION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MUCOLIPIDOSES; TIME FACTORS;

EID: 27644586728     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi063     Document Type: Article

References (12)

1. Thomas GH. Disorders of glycoprotein degradation: α-mannosidosis, β-mannosidosis, fucosidosis and sialidosis. In: Scriver CR, Beaudet A, Sly WS, Valle D (eds). The Metabolic and Molecular Bases of Inherited Disease, vol III, 8th Edn. New York: McGraw-Hill; 2001, pp. 3507-3534
2. Lowden JA, O'Brien JS. Sialidosis: A review of human neuraminidase deficiency. Am J Hum Genet 1979; 31: 1-18
3. Lyon G, Adams RD, Kolodny EH. Neurology of hereditary metabolic diseases of children. 2nd Edn. New York: McGraw-Hill; 1996, pp. 61-62
4. Vellodi A, Young EP, Cooper A et al. Bone marrow transplantation for mucopolysaccharidosis type I: Experience of two British centres. Arch Dis Child 1997; 76: 92-99
5. Ohshima T, Schiffmann R, Murray GJ et al. Aging accentuates and bone marrow transplantation ameliorates metabolic defects in Fabry disease mice. Proc Natl Acad Sci USA 1999; 96: 6423-6427
6. Maroteaux P, Humbel R, Strecker G, Michalski JC, Mande R. Un nouveau type de sialidose avec atteinte rénale: La néphrosialidose. Etude clinique, radiologique et nosologique. Arch Fr Pédiatr 1978; 35: 819-829
7. Le Sec G, Stanescu R, Lyon G. Un nouveau type de sialidose avec atteinte rénale: La néphrosialidose. Etude anatomique. Arch Fr Pédiatr 1978; 35: 830-844
8. Roth KS, Chan JC, Ghatak NR, Mamunes P, Miller WW, O'Brien JS. Acid α-neuraminidase deficiency: A nephropathic phenotype? Clin Genet 1988; 34: 185-194
9. Kashtan CE, Nevins TE, Posalaky Z, Vernier RL, Fish AJ. Proteinuria in a child with sialidosis: Case report and histological studies. Pediatr Nephrol 1989; 3: 166-174
10. Toyooka K, Fujimura H, Yoshikawa H et al. Nephrosialidosis: ultrastructural and lectin histochemical study. Acta Neuropathol (Berl) 1993; 86: 198-205
11. Wang D, Bonten EJ, Yogalingam G, Mann L, d'Azzo A. Short-term, high dose enzyme replacement therapy in sialidosis mice. Mol Genet Metab 2005; 85: 181-189
12. Kakkis E, Lester T, Yang R et al. Successful induction of immune tolerance to enzyme replacement therapy in canine mucopolysaccharidosis I. Proc Natl Acad Sci USA 2004; 101: 829-834